.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
AstraZeneca
Fuji
Fish and Richardson
Cantor Fitzgerald
Deloitte
Citi
Boehringer Ingelheim
US Department of Justice
Johnson and Johnson

Generated: July 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020343

« Back to Dashboard
NDA 020343 describes PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. Additional details are available on the PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER profile page.

The generic ingredient in PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER is milrinone lactate. There are nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.

Summary for NDA: 020343

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 10MG BASE/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Aug 9, 1994TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 15MG BASE/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Aug 9, 1994TE:RLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 20MG BASE/100ML (EQ 0.2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Aug 9, 1994TE:RLD:Yes

Expired Orange Book Patents for NDA: 020343

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us
PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
milrinone lactate
INJECTABLE;INJECTION020343-001Aug 9, 1994► Subscribe► Subscribe
Sanofi Aventis Us
PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
milrinone lactate
INJECTABLE;INJECTION020343-003Aug 9, 1994► Subscribe► Subscribe
Sanofi Aventis Us
PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER
milrinone lactate
INJECTABLE;INJECTION020343-002Aug 9, 1994► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
AstraZeneca
Queensland Health
Deloitte
Novartis
McKesson
Merck
Argus Health
Moodys
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot